Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

BACKGROUND: The REDUCE-RISK trial was set up to compare the effectiveness of weekly subcutaneously administered methotrexate with daily oral azathioprine or 6-mercaptopurine in low-risk Crohn disease (CD) or subcutaneously administered adalimumab (ADA) in high-risk CD in a pediatric population (age...

Descripción completa

Detalles Bibliográficos
Autores principales: Neyt, Mattias, Christiaens, Annick, Aloi, Marina, de Ridder, Lissy, Croft, Nicholas M, Koletzko, Sibylle, Levine, Arie, Turner, Dan, Russell, Richard K, Ruemmele, Frank M, Veereman, Gigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870354/
https://www.ncbi.nlm.nih.gov/pubmed/33492239
http://dx.doi.org/10.2196/13888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870354/
https://www.ncbi.nlm.nih.gov/pubmed/33492239
http://dx.doi.org/10.2196/13888

Ejemplares similares